companydata.dkcompanydata.dk

Epoqe Pharma ApS: Financial statements 2024

CVR: 42443670

Source: annual report 2024, Danish Business Authority

01/07/2023 – 30/06/2024

Epoqe Pharma ApS (CVR 42443670) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,273,171 and a net result of DKK -135,919 compared with DKK -15,427 the year before. Equity in the 2024 report amounted to DKK -18,267. The company had 2 employees in the financial year.

Gross Profit
DKK 1,273,171
Profit/Loss
DKK -135,919
Equity
DKK -18,267
Total Assets
DKK 1,111,063
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-1.3 mio.-136 t.-18 t.2
2023--19 t.-15 t.118 t.-
2022--17 t.-18 t.133 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Henrijette Elsebeth Richter joins the board of Epoqe Pharma ApSSep 19, 2024

As of September 19, 2024, Henrijette Elsebeth Richter has joined the board of directors of Epoqe Pharma ApS.

Anette Sams Nielsen joins the board of Epoqe Pharma ApSSep 19, 2024

As of September 19, 2024, Anette Sams Nielsen has joined the board of directors of Epoqe Pharma ApS.

Jan Bjerrum Bach leaves the board of Epoqe Pharma ApSSep 19, 2024

As of September 19, 2024, Jan Bjerrum Bach has left the board of directors of Epoqe Pharma ApS.

Alejandra Maria Cristina Bonifacini Mørk leaves the board of Epoqe Pharma ApSSep 19, 2024

As of September 19, 2024, Alejandra Maria Cristina Bonifacini Mørk has left the board of directors of Epoqe Pharma ApS.

Edvince ApS registered as owner of Epoqe Pharma ApSSep 19, 2024

As of September 19, 2024, Edvince ApS is registered as an owner of Epoqe Pharma ApS with an ownership share of 5%.

About Epoqe Pharma ApS

Epoqe Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Patentselskabet af 31. maj 2021 ApS.. The management consists of Mark Stephen Sumeray. The board consists of Anders Gaarsdal Holst (chair), Henrijette Elsebeth Richter, Lars Gredsted and Mark Stephen Sumeray. The company's owners include LUNDBECKFOND INVEST A/S, Helms & Sams ApS and CMCGreenhouse ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK -13,719,778 and a net result of DKK -13,943,884 compared with DKK -135,919 the year before. Equity in the 2025 report amounted to DKK 30,042,156.

Source: annual report 2025, Danish Business Authority

Other financial years